secwatch.observer — SEC 8-K summary
======================================

Issuer:     X4 Pharmaceuticals, Inc (XFOR)
CIK:        0001501697
Form:       8-K
Filed at:   2025-04-18T23:59:59+00:00
Accession:  0001628280-25-018389
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

X4 Pharma stockholders approve reverse stock split; ratio 1:15 to 1:30 to be set by board
--------------------------------------------------------------------------------

- Special meeting held April 17, 2025; ~79% of outstanding shares (137.2M of 173.7M) present, forming quorum.
- Reverse split approved: 113.0M FOR, 24.0M AGAINST, 224k abstentions; no broker non-votes.
- Amendment authorizes board to set exact ratio between 1-for-15 and 1-for-30.
- Related Proposal 2 was not presented because Proposal 1 passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501697/000162828025018389/0001628280-25-018389-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501697/000162828025018389/xfor-20250417.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-018389

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer